Quote:There is a lot here to fight to protect
I'm not sure what you're referring to? Looking through the last 10-K, the only thing I see that might possibly warrant protection is this:
"In 2010, Solterra entered into an agreement with a third-party provider of industrial process equipment to develop a proprietary process for continuous flow production of QDs and TQDs under which Solterra retained all ownership and rights to the design and any related intellectual property."
Is that what you're referring to, or are you thinking that there have been other developments in Solterra that have not been made public?
I don't believe Solterra has any patents related to the equipment or process, so I'm not sure what there is to protect? QMC, not Solterra, owns the Bayer patents "covering the high-volume manufacture of QDs" according to their financials.
The next question is, where did the debt at Solterra come from? Did UA or Schloss get a court judgement against the company? I didn't see anything else in the last 10-K that might lead to Solterra owing money. If not, I don't see how either could force them into CH11. Did Solterra start piling on debt after they stopped reporting?
When we first started hearing about Pasaca loaning them money, I wrote at the time that it looked a lot it might be a "loan-to-own" type of scenario. Is that possibly what we're seeing here?
